LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Are Data Driving Our Ambulances? Liberal Use of Tranexamic Acid in the Prehospital Setting.

    Brito, Alexandra M P / Stettler, Gregory / Fram, Madeline R / Winslow, James / Martin, R Shayne

    The American surgeon

    2023  Volume 90, Issue 4, Page(s) 703–709

    Abstract: Background: Current data on tranexamic acid (TXA) supports early administration for severe hemorrhagic shock. Administration by EMS has been facilitated by developing protocols and standing orders informed by these data. In this study, patterns of TXA ... ...

    Abstract Background: Current data on tranexamic acid (TXA) supports early administration for severe hemorrhagic shock. Administration by EMS has been facilitated by developing protocols and standing orders informed by these data. In this study, patterns of TXA use by EMS agencies serving a large level 1 trauma center were examined. We hypothesized that current widespread TXA use often includes administration outside of data-driven indications.
    Methods: The trauma registry at a level 1 trauma center was queried for patients who received TXA. To determine the practice patterns and appropriateness of administration of TXA, patients' physiologic state in the prehospital environment based on EMS records, physiologic state on arrival to hospital, and interventions performed in both settings were examined. Over 20 separately managed EMS systems that administer TXA transport patients to this trauma center, allowing for a broad survey of practices.
    Results: From 2016 to 2021 1089 patients received TXA, 406 (37.3%) having treatment initiated by EMS services. Of these, the average prehospital systolic blood pressure (SBP) was 108.2 mmHg and initial ED SBP was 107.8 mmHg. Only 58.4% of these patients received blood transfusion after arrival to this trauma center. Compliance with standard indications was low with only 14.6% of administrations meeting any data-driven SBP indication. Similar levels of compliance were seen across high volume EMS services.
    Discussion: Tranexamic acid use has become common in trauma and has been adopted by many EMS systems. These results indicate TXA in the prehospital setting is over-used as administration is not being limited to indications that have shown benefit in prior data.
    MeSH term(s) Humans ; Ambulances ; Tranexamic Acid/therapeutic use ; Hospitals ; Patient Compliance ; Registries
    Chemical Substances Tranexamic Acid (6T84R30KC1)
    Language English
    Publishing date 2023-10-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 202465-2
    ISSN 1555-9823 ; 0003-1348
    ISSN (online) 1555-9823
    ISSN 0003-1348
    DOI 10.1177/00031348231209525
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The COST of liver disease: The Cirrhosis Outcomes Score in Trauma Study.

    Appelbaum, Rachel D / Riera, Katherine M / Fram, Madeline R / Russell, Gregory B / Ii, Samuel P Carmichael / Martin, R Shayn / Hoth, J Jason / Mowery, Nathan T / Nunn, Andrew M

    Injury

    2023  Volume 54, Issue 5, Page(s) 1374–1378

    Abstract: Background: Cirrhosis in trauma patients is an indicator of poor prognosis, but current trauma injury grading systems do not take into account liver dysfunction as a risk factor. Our objective was to construct a simple clinical mortality prediction ... ...

    Abstract Background: Cirrhosis in trauma patients is an indicator of poor prognosis, but current trauma injury grading systems do not take into account liver dysfunction as a risk factor. Our objective was to construct a simple clinical mortality prediction model in cirrhotic trauma patients: Cirrhosis Outcomes Score in Trauma (COST).
    Methods: Trauma patients with pre-existing cirrhosis or liver dysfunction who were admitted to our ACS Level I trauma center between 2013 and 2021 were reviewed. Patients with significant acute liver trauma (AAST Grade ≥ 3) or those that developed acute liver dysfunction while admitted were excluded. Demographics as well as ISS, MELD, complications, and mortality were evaluated. COST was defined as the sum of age, ISS, and MELD. Univariate and multivariable analysis was used to determine independent predictors of mortality. The area under the receiver operating curve (AUROC) was calculated to assess the ability of COST to predict mortality.
    Results: A total of 318 patients were analyzed of which the majority were males 214 (67.3%) who suffered blunt trauma 305 (95.9%). Mortality at 30-days, 60-days, and 90-days was 20.4%, 23.6%, and 25.5%, respectively. COST was associated with inpatient, 30-day, and 90-day mortality on regression analyses and the AUROC for COST predicting mortality at these respective time points was 0.810, 0.801, and 0.813.
    Conclusion: Current trauma injury grading systems do not take into account liver dysfunction as a risk factor. COST is highly predictive of mortality in cirrhotic trauma patients. The simplicity of the score makes it useful in guiding clinical care and in optimizing goals of care discussions. Future studies to validate this prediction model are required prior to clinical use.
    MeSH term(s) Male ; Humans ; Female ; Liver Cirrhosis/complications ; Severity of Illness Index ; Prognosis ; Retrospective Studies ; ROC Curve ; Liver Diseases
    Language English
    Publishing date 2023-02-03
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 218778-4
    ISSN 1879-0267 ; 0020-1383
    ISSN (online) 1879-0267
    ISSN 0020-1383
    DOI 10.1016/j.injury.2023.02.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Risk factors for administration of additional reversal following neuromuscular blockade with rocuronium in children: A retrospective case-control study.

    Vishneski, Susan R / Saha, Amit K / Fram, Madeline R / Templeton, Leah B / Lee, Lisa K / Ririe, Douglas G / Goenaga-Diaz, Eduardo Javier / Smith, Laura Daniela / Templeton, Thomas Wesley

    Paediatric anaesthesia

    2022  Volume 32, Issue 8, Page(s) 916–925

    Abstract: Background: The prevalence and risk factors for residual neuromuscular blockade in children remain poorly characterized. We hypothesize that specific patient and anesthetic risk factors may be associated with the administration of additional reversal in ...

    Abstract Background: The prevalence and risk factors for residual neuromuscular blockade in children remain poorly characterized. We hypothesize that specific patient and anesthetic risk factors may be associated with the administration of additional reversal in children following initial reversal of rocuronium with neostigmine.
    Methods: Our electronic health record was queried for patients <18 years of age who received rocuronium and reversal with neostigmine from 2017 through 2020. Patients receiving other nondepolarizing neuromuscular blocking drugs were excluded. The outcome of interest was defined as the administration of additional neostigmine or sugammadex following primary reversal with neostigmine. Time between the last dose of rocuronium and initial dose of neostigmine, and the cumulative dose of rocuronium were dichotomized. These were combined with other covariates including age, weight, sex, racial group, procedure type, ASA physical status, >1 rocuronium dose administered during the procedure, initial neostigmine dose <0.05 mg kg
    Results: During the study period, 101/6373 (1.58%) patients received rocuronium and additional reversal. Dichotomization of time between last dose of rocuronium and neostigmine yielded <28 min since the last dose of rocuronium and cumulative dose of rocuronium >0.45 mg kg
    Conclusion: Risk factors associated with the administration of additional reversal included time <28 min from the last dose of rocuronium to initial dose of neostigmine, cumulative dose of rocuronium >0.45 mg kg
    MeSH term(s) Androstanols ; Anesthetics ; Case-Control Studies ; Child ; Humans ; Neostigmine/pharmacology ; Neuromuscular Blockade/adverse effects ; Neuromuscular Blockade/methods ; Neuromuscular Diseases ; Neuromuscular Nondepolarizing Agents ; Retrospective Studies ; Risk Factors ; Rocuronium ; gamma-Cyclodextrins/adverse effects
    Chemical Substances Androstanols ; Anesthetics ; Neuromuscular Nondepolarizing Agents ; gamma-Cyclodextrins ; Neostigmine (3982TWQ96G) ; Rocuronium (WRE554RFEZ)
    Language English
    Publishing date 2022-05-01
    Publishing country France
    Document type Journal Article
    ZDB-ID 1086049-6
    ISSN 1460-9592 ; 1155-5645
    ISSN (online) 1460-9592
    ISSN 1155-5645
    DOI 10.1111/pan.14463
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top